Takashi Ishigami
About
In The Last Decade
Takashi Ishigami
21 papers receiving 516 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 319
- Oncology 124
- Cancer Research 111
- Epidemiology 87
- Cell Biology 77
Countries citing papers authored by Takashi Ishigami
This map shows the geographic impact of Takashi Ishigami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Ishigami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Ishigami more than expected).
Fields of papers citing papers by Takashi Ishigami
This network shows the impact of papers produced by Takashi Ishigami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Ishigami. The network helps show where Takashi Ishigami may publish in the future.
Co-authorship network of co-authors of Takashi Ishigami
This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Ishigami. A scholar is included among the top collaborators of Takashi Ishigami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Ishigami. Takashi Ishigami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 34 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 59 | |
| 6 | Loss of heterozvgosity in oral cancer | 0 |
| 7 | 1 | |
| 8 | 2 | |
| 9 | 8 | |
| 10 | 66 | |
| 11 | 24 | |
| 12 | 17 | |
| 13 | 32 | |
| 14 | 34 | |
| 15 | 64 | |
| 16 | 22 | |
| 17 | 60 | |
| 18 | 1 | |
| 19 | [ELISA for platelet-associated IgG, IgM, and C3, and their clinical application]. | 1 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.